Global Botulinum Toxin Market – Industry Analysis and Forecast (2019-2026) – by Product Type, End-user, Application, and Region.

Global Botulinum Toxin Market was valued US$ XX Bn in 2018 and is expected to reach US$ 8.17 Bn by 2026, at CAGR of XX% during forecast period. Global Botulinum Toxin MarketTo know about the Research Methodology :- Request Free Sample Report Botulinum toxin is a neurotoxin and has seven different antigenic forms namely Botulinum toxin - A, B, C, D, E, F and G which are produced by an anaerobic bacterium, clostridium botulinum. Botulinum toxin is extensively used for aesthetic purposes. At present, a few products of Botulinum toxin - A and only one product of Botulinum toxin - B are commercially available in the market.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Rising incidence of medical conditions such as chronic migraine, cervical dystonia, muscle spasticity, etc., will boost the botulinum toxin market growth. Also, the presence of major industry players coupled with growing product demand among the millennials as well as the middle-aged population will significantly drive the U.S. market. The global botulinum toxins market will witness considerable growth in the coming years because of the inflating demand for botulinum toxins across the globe. On the other hand, high costs associated with aesthetic procedures and poor reimbursement coverage for such procedures are a few major growths hampering factors. Based on the application, the therapeutics botulinum toxin segment accounted for a market share of around 57.5% in 2018. The growing prevalence of spasticity and cervical dystonia coupled with the increasing incidence of migraine will drive the therapeutics botulinum toxin segment. Moreover, increasing capital investments for R&D of such products will further supplement the botulinum toxin market growth. Also, Aesthetic applications of botulinum toxin are expected to grow at XX% CAGR throughout the forecast timeframe. Botulinum toxin is mainly used as a treatment to reduce the appearance of fine lines and facial wrinkles. Regionally, the North America market expected to capture the largest revenue share of XX% during the forecast period. Higher disposable income and availability of a variety of aesthetic procedures for enhancing external appearance is pushing the demand for the botulinum toxin in North America. As well, Asia Pacific is expected to exhibit the highest growth in the future thanks to aging demographics and rising disposable income resulting in a higher demand for anti-aging products. Also, the growing social consciousness regarding the commercial availability of these products in the Asia Pacific is expected to augment the growth of the botulinum toxin market in the future. The high demand for the botulinum toxin has led to numerous product innovations. Resulting from the high demand, there has been a subsequent rise in the number of product launches globally. The report covers recent development of the market botulinum toxin, such as in January 2019, Huon's Global declared the launch of a new botulinum toxin product in Korea. The Liztox was designed specifically to treat forehead wrinkles. The objective of the report is to present comprehensive analysis of global botulinum toxin market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding global botulinum toxin market dynamics, structure by analyzing the market segments, and project the global botulinum toxin market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the global botulinum toxin market make the report investor’s guide.

Scope of the Global Botulinum Toxin Market: Inquire before buying

Global Botulinum Toxin Market, By Product Type

• Botulinum Toxin Type A • Botulinum Toxin Type B

Global Botulinum Toxin Market, By End-user

• Specialty & Dermatology Clinics • Hospitals & Clinics • Others

Global Botulinum Toxin Market, By Application

• Aesthetic • Therapeutics

Global Botulinum Toxin Market, By Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Key players operating in Global Botulinum Toxin Market

• Allergan Plc. • Ipsen • Revance Therapeutics, Inc. • Merz Pharma • Medytox • US WorldMeds, LLC (Solstice Neurosciences, LLC) • Galderma laboratories • Lanzhou Institute of Biological Products Co., Ltd. • AbbVie Inc • Eisai Co., Ltd. • Hugel Inc. • Ipsen and Revance Therapeutics, Inc. • Evolus, Inc. • Hugh Source (International) Ltd. • Daewoong Pharmaceuticals Co.Ltd.

Global Botulinum Toxin Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Botulinum Toxin Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Botulinum Toxin Market Analysis and Forecast 6.1. Global Botulinum Toxin Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Botulinum Toxin Market Analysis and Forecast, By Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Botulinum Toxin Market Value Share Analysis, By Application 7.4. Global Botulinum Toxin Market Size (US$ Bn) Forecast, By Application 7.5. Global Botulinum Toxin Market Analysis, By Application 7.6. Global Botulinum Toxin Market Attractiveness Analysis, By Application 8. Global Botulinum Toxin Market Analysis and Forecast, By Product Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Botulinum Toxin Market Value Share Analysis, By Product Type 8.4. Global Botulinum Toxin Market Size (US$ Bn) Forecast, By Product Type 8.5. Global Botulinum Toxin Market Analysis, By Product Type 8.6. Global Botulinum Toxin Market Attractiveness Analysis, By Product Type 9. Global Botulinum Toxin Market Analysis and Forecast, By End-user 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Botulinum Toxin Market Value Share Analysis, By End-user 9.4. Global Botulinum Toxin Market Size (US$ Bn) Forecast, By End-user 9.5. Global Botulinum Toxin Market Analysis, By End-user 9.6. Global Botulinum Toxin Market Attractiveness Analysis, By End-user 10. Global Botulinum Toxin Market Analysis, by Region 10.1. Global Botulinum Toxin Market Value Share Analysis, by Region 10.2. Global Botulinum Toxin Market Size (US$ Bn) Forecast, by Region 10.3. Global Botulinum Toxin Market Attractiveness Analysis, by Region 11. North America Botulinum Toxin Market Analysis 11.1. Key Findings 11.2. North America Botulinum Toxin Market Overview 11.3. North America Botulinum Toxin Market Value Share Analysis, By Application 11.4. North America Botulinum Toxin Market Forecast, By Application 11.4.1. Aesthetic 11.4.2. Therapeutics 11.5. North America Botulinum Toxin Market Value Share Analysis, By Product Type 11.6. North America Botulinum Toxin Market Forecast, By Product Type 11.6.1. Botulinum Toxin Type A 11.6.2. Botulinum Toxin Type B 11.7. North America Botulinum Toxin Market Value Share Analysis, By End-user 11.8. North America Botulinum Toxin Market Forecast, By End-user 11.8.1. Specialty & Dermatology Clinics 11.8.2. Hospitals & Clinics 11.8.3. Others 11.9. North America Botulinum Toxin Market Value Share Analysis, by Country 11.10. North America Botulinum Toxin Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Botulinum Toxin Market Analysis, by Country 11.12. U.S. Botulinum Toxin Market Forecast, By Application 11.12.1. Aesthetic 11.12.2. Therapeutics 11.13. U.S. Botulinum Toxin Market Forecast, By Product Type 11.13.1. Botulinum Toxin Type A 11.13.2. Botulinum Toxin Type B 11.14. U.S. Botulinum Toxin Market Forecast, By End-user 11.14.1. Specialty & Dermatology Clinics 11.14.2. Hospitals & Clinics 11.14.3. Others 11.15. Canada Botulinum Toxin Market Forecast, By Application 11.15.1. Aesthetic 11.15.2. Therapeutics 11.16. Canada Botulinum Toxin Market Forecast, By Product Type 11.16.1. Botulinum Toxin Type A 11.16.2. Botulinum Toxin Type B 11.17. Canada Botulinum Toxin Market Forecast, By End-user 11.17.1. Specialty & Dermatology Clinics 11.17.2. Hospitals & Clinics 11.17.3. Others 11.18. North America Botulinum Toxin Market Attractiveness Analysis 11.18.1. By Application 11.18.2. By Product Type 11.18.3. By End-user 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Botulinum Toxin Market Analysis 12.1. Key Findings 12.2. Europe Botulinum Toxin Market Overview 12.3. Europe Botulinum Toxin Market Value Share Analysis, By Application 12.4. Europe Botulinum Toxin Market Forecast, By Application 12.4.1. Aesthetic 12.4.2. Therapeutics 12.5. Europe Botulinum Toxin Market Value Share Analysis, By Product Type 12.6. Europe Botulinum Toxin Market Forecast, By Product Type 12.6.1. Botulinum Toxin Type A 12.6.2. Botulinum Toxin Type B 12.7. Europe Botulinum Toxin Market Value Share Analysis, By End-user 12.8. Europe Botulinum Toxin Market Forecast, By End-user 12.8.1. Specialty & Dermatology Clinics 12.8.2. Hospitals & Clinics 12.8.3. Others 12.9. Europe Botulinum Toxin Market Value Share Analysis, by Country 12.10. Europe Botulinum Toxin Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Botulinum Toxin Market Analysis, by Country 12.12. Germany Botulinum Toxin Market Forecast, By Application 12.12.1. Aesthetic 12.12.2. Therapeutics 12.13. Germany Botulinum Toxin Market Forecast, By Product Type 12.13.1. Botulinum Toxin Type A 12.13.2. Botulinum Toxin Type B 12.14. Germany Botulinum Toxin Market Forecast, By End-user 12.14.1. Specialty & Dermatology Clinics 12.14.2. Hospitals & Clinics 12.14.3. Others 12.15. U.K. Botulinum Toxin Market Forecast, By Application 12.15.1. Aesthetic 12.15.2. Therapeutics 12.16. U.K. Botulinum Toxin Market Forecast, By Product Type 12.16.1. Botulinum Toxin Type A 12.16.2. Botulinum Toxin Type B 12.17. U.K. Botulinum Toxin Market Forecast, By End-user 12.17.1. Specialty & Dermatology Clinics 12.17.2. Hospitals & Clinics 12.17.3. Others 12.18. France Botulinum Toxin Market Forecast, By Application 12.18.1. Aesthetic 12.18.2. Therapeutics 12.19. France Botulinum Toxin Market Forecast, By Product Type 12.19.1. Botulinum Toxin Type A 12.19.2. Botulinum Toxin Type B 12.20. France Botulinum Toxin Market Forecast, By End-user 12.20.1. Specialty & Dermatology Clinics 12.20.2. Hospitals & Clinics 12.20.3. Others 12.21. Italy Botulinum Toxin Market Forecast, By Application 12.21.1. Aesthetic 12.21.2. Therapeutics 12.22. Italy Botulinum Toxin Market Forecast, By Product Type 12.22.1. Botulinum Toxin Type A 12.22.2. Botulinum Toxin Type B 12.23. Italy Botulinum Toxin Market Forecast, By End-user 12.23.1. Specialty & Dermatology Clinics 12.23.2. Hospitals & Clinics 12.23.3. Others 12.24. Spain Botulinum Toxin Market Forecast, By Application 12.24.1. Aesthetic 12.24.2. Therapeutics 12.25. Spain Botulinum Toxin Market Forecast, By Product Type 12.25.1. Botulinum Toxin Type A 12.25.2. Botulinum Toxin Type B 12.26. Spain Botulinum Toxin Market Forecast, By End-user 12.26.1. Specialty & Dermatology Clinics 12.26.2. Hospitals & Clinics 12.26.3. Others 12.27. Rest of Europe Botulinum Toxin Market Forecast, By Application 12.27.1. Aesthetic 12.27.2. Therapeutics 12.28. Rest of Europe Botulinum Toxin Market Forecast, By Product Type 12.28.1. Botulinum Toxin Type A 12.28.2. Botulinum Toxin Type B 12.29. Rest of Europe Botulinum Toxin Market Forecast, By End-user 12.29.1. Specialty & Dermatology Clinics 12.29.2. Hospitals & Clinics 12.29.3. Others 12.30. Europe Botulinum Toxin Market Attractiveness Analysis 12.30.1. By Application 12.30.2. By Product Type 12.30.3. By End-user 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Botulinum Toxin Market Analysis 13.1. Key Findings 13.2. Asia Pacific Botulinum Toxin Market Overview 13.3. Asia Pacific Botulinum Toxin Market Value Share Analysis, By Application 13.4. Asia Pacific Botulinum Toxin Market Forecast, By Application 13.4.1. Aesthetic 13.4.2. Therapeutics 13.5. Asia Pacific Botulinum Toxin Market Value Share Analysis, By Product Type 13.6. Asia Pacific Botulinum Toxin Market Forecast, By Product Type 13.6.1. Botulinum Toxin Type A 13.6.2. Botulinum Toxin Type B 13.7. Asia Pacific Botulinum Toxin Market Value Share Analysis, By End-user 13.8. Asia Pacific Botulinum Toxin Market Forecast, By End-user 13.8.1. Specialty & Dermatology Clinics 13.8.2. Hospitals & Clinics 13.8.3. Others 13.9. Asia Pacific Botulinum Toxin Market Value Share Analysis, by Country 13.10. Asia Pacific Botulinum Toxin Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Botulinum Toxin Market Analysis, by Country 13.12. China Botulinum Toxin Market Forecast, By Application 13.12.1. Aesthetic 13.12.2. Therapeutics 13.13. China Botulinum Toxin Market Forecast, By Product Type 13.13.1. Botulinum Toxin Type A 13.13.2. Botulinum Toxin Type B 13.14. China Botulinum Toxin Market Forecast, By End-user 13.14.1. Specialty & Dermatology Clinics 13.14.2. Hospitals & Clinics 13.14.3. Others 13.15. India Botulinum Toxin Market Forecast, By Application 13.15.1. Aesthetic 13.15.2. Therapeutics 13.16. India Botulinum Toxin Market Forecast, By Product Type 13.16.1. Botulinum Toxin Type A 13.16.2. Botulinum Toxin Type B 13.17. India Botulinum Toxin Market Forecast, By End-user 13.17.1. Specialty & Dermatology Clinics 13.17.2. Hospitals & Clinics 13.17.3. Others 13.18. Japan Botulinum Toxin Market Forecast, By Application 13.18.1. Aesthetic 13.18.2. Therapeutics 13.19. Japan Botulinum Toxin Market Forecast, By Product Type 13.19.1. Botulinum Toxin Type A 13.19.2. Botulinum Toxin Type B 13.20. Japan Botulinum Toxin Market Forecast, By End-user 13.20.1. Specialty & Dermatology Clinics 13.20.2. Hospitals & Clinics 13.20.3. Others 13.21. ASEAN Botulinum Toxin Market Forecast, By Application 13.21.1. Aesthetic 13.21.2. Therapeutics 13.22. ASEAN Botulinum Toxin Market Forecast, By Product Type 13.22.1. Botulinum Toxin Type A 13.22.2. Botulinum Toxin Type B 13.23. ASEAN Botulinum Toxin Market Forecast, By End-user 13.23.1. Specialty & Dermatology Clinics 13.23.2. Hospitals & Clinics 13.23.3. Others 13.24. Rest of Asia Pacific Botulinum Toxin Market Forecast, By Application 13.24.1. Aesthetic 13.24.2. Therapeutics 13.25. Rest of Asia Pacific Botulinum Toxin Market Forecast, By Product Type 13.25.1. Botulinum Toxin Type A 13.25.2. Botulinum Toxin Type B 13.26. Rest of Asia Pacific Botulinum Toxin Market Forecast, By End-user 13.26.1. Specialty & Dermatology Clinics 13.26.2. Hospitals & Clinics 13.26.3. Others 13.27. Asia Pacific Botulinum Toxin Market Attractiveness Analysis 13.27.1. By Application 13.27.2. By Product Type 13.27.3. By End-user 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Botulinum Toxin Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Botulinum Toxin Market Overview 14.3. Middle East & Africa Botulinum Toxin Market Value Share Analysis, By Application 14.4. Middle East & Africa Botulinum Toxin Market Forecast, By Application 14.4.1. Aesthetic 14.4.2. Therapeutics 14.5. Middle East & Africa Botulinum Toxin Market Value Share Analysis, By Product Type 14.6. Middle East & Africa Botulinum Toxin Market Forecast, By Product Type 14.6.1. Botulinum Toxin Type A 14.6.2. Botulinum Toxin Type B 14.7. Middle East & Africa Botulinum Toxin Market Value Share Analysis, By End-user 14.8. Middle East & Africa Botulinum Toxin Market Forecast, By End-user 14.8.1. Specialty & Dermatology Clinics 14.8.2. Hospitals & Clinics 14.8.3. Others 14.9. Middle East & Africa Botulinum Toxin Market Value Share Analysis, by Country 14.10. Middle East & Africa Botulinum Toxin Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Botulinum Toxin Market Analysis, by Country 14.12. GCC Botulinum Toxin Market Forecast, By Application 14.12.1. Aesthetic 14.12.2. Therapeutics 14.13. GCC Botulinum Toxin Market Forecast, By Product Type 14.13.1. Botulinum Toxin Type A 14.13.2. Botulinum Toxin Type B 14.14. GCC Botulinum Toxin Market Forecast, By End-user 14.14.1. Specialty & Dermatology Clinics 14.14.2. Hospitals & Clinics 14.14.3. Others 14.15. South Africa Botulinum Toxin Market Forecast, By Application 14.15.1. Aesthetic 14.15.2. Therapeutics 14.16. South Africa Botulinum Toxin Market Forecast, By Product Type 14.16.1. Botulinum Toxin Type A 14.16.2. Botulinum Toxin Type B 14.17. South Africa Botulinum Toxin Market Forecast, By End-user 14.17.1. Specialty & Dermatology Clinics 14.17.2. Hospitals & Clinics 14.17.3. Others 14.18. Rest of Middle East & Africa Botulinum Toxin Market Forecast, By Application 14.18.1. Aesthetic 14.18.2. Therapeutics 14.19. Rest of Middle East & Africa Botulinum Toxin Market Forecast, By Product Type 14.19.1. Botulinum Toxin Type A 14.19.2. Botulinum Toxin Type B 14.20. Rest of Middle East & Africa Botulinum Toxin Market Forecast, By End-user 14.20.1. Specialty & Dermatology Clinics 14.20.2. Hospitals & Clinics 14.20.3. Others 14.21. Middle East & Africa Botulinum Toxin Market Attractiveness Analysis 14.21.1. By Application 14.21.2. By Product Type 14.21.3. By End-user 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Botulinum Toxin Market Analysis 15.1. Key Findings 15.2. South America Botulinum Toxin Market Overview 15.3. South America Botulinum Toxin Market Value Share Analysis, By Application 15.4. South America Botulinum Toxin Market Forecast, By Application 15.4.1. Aesthetic 15.4.2. Therapeutics 15.5. South America Botulinum Toxin Market Value Share Analysis, By Product Type 15.6. South America Botulinum Toxin Market Forecast, By Product Type 15.6.1. Botulinum Toxin Type A 15.6.2. Botulinum Toxin Type B 15.7. South America Botulinum Toxin Market Value Share Analysis, By End-user 15.8. South America Botulinum Toxin Market Forecast, By End-user 15.8.1. Specialty & Dermatology Clinics 15.8.2. Hospitals & Clinics 15.8.3. Others 15.9. South America Botulinum Toxin Market Value Share Analysis, by Country 15.10. South America Botulinum Toxin Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Botulinum Toxin Market Analysis, by Country 15.12. Brazil Botulinum Toxin Market Forecast, By Application 15.12.1. Aesthetic 15.12.2. Therapeutics 15.13. Brazil Botulinum Toxin Market Forecast, By Product Type 15.13.1. Botulinum Toxin Type A 15.13.2. Botulinum Toxin Type B 15.14. Brazil Botulinum Toxin Market Forecast, By End-user 15.14.1. Specialty & Dermatology Clinics 15.14.2. Hospitals & Clinics 15.14.3. Others 15.15. Mexico Botulinum Toxin Market Forecast, By Application 15.15.1. Aesthetic 15.15.2. Therapeutics 15.16. Mexico Botulinum Toxin Market Forecast, By Product Type 15.16.1. Botulinum Toxin Type A 15.16.2. Botulinum Toxin Type B 15.17. Mexico Botulinum Toxin Market Forecast, By End-user 15.17.1. Specialty & Dermatology Clinics 15.17.2. Hospitals & Clinics 15.17.3. Others 15.18. Rest of South America Botulinum Toxin Market Forecast, By Application 15.18.1. Aesthetic 15.18.2. Therapeutics 15.19. Rest of South America Botulinum Toxin Market Forecast, By Product Type 15.19.1. Botulinum Toxin Type A 15.19.2. Botulinum Toxin Type B 15.20. Rest of South America Botulinum Toxin Market Forecast, By End-user 15.20.1. Specialty & Dermatology Clinics 15.20.2. Hospitals & Clinics 15.20.3. Others 15.21. South America Botulinum Toxin Market Attractiveness Analysis 15.21.1. By Application 15.21.2. By Product Type 15.21.3. By End-user 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Allergan Plc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Ipsen 16.3.3. Revance Therapeutics, Inc. 16.3.4. Merz Pharma 16.3.5. Medytox 16.3.6. US WorldMeds, LLC (Solstice Neurosciences, LLC) 16.3.7. Galderma laboratories 16.3.8. Lanzhou Institute of Biological Products Co., Ltd. 16.3.9. AbbVie Inc 16.3.10. Eisai Co., Ltd. 16.3.11. Hugel Inc. 16.3.12. Ipsen and Revance Therapeutics, Inc. 16.3.13. Evolus, Inc. 16.3.14. Hugh Source (International) Ltd. 16.3.15. Daewoong Pharmaceuticals Co.Ltd. 17. Primary Key Insights

About This Report

Report ID 37286
Category Healthcare
Published Date Nov 2019
Updated Date Oct 2020
Contact Us